Dose Escalation Study of Revlimid With Fludarabine-Rituximab for CLL/SLL
- Status
- TERMINATED
- Phase
- PHASE1
Clinical Trials Related to Lenalidomide
Related studies linked through entity extraction aliases.
Lenalidomide in Relapsed or Refractory Classical Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Phase II Study of Dexamethasone, Thalidomide and Lenalidomide for Subjects With Relapsed or Refractory Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE2
Phase II Study of Thalidomide, Clarithromycin, Lenalidomide, and Dexamethasone for Newly Diagnosed Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Fludarabine, Rituximab, and Lenalidomide in Minimally Treated/Untreated Patients With Chronic Lymphocytic Leukemia (CLL)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Lenalidomide as Initial Treatment of Patients With Chronic Lymphocytic Leukemia (CLL) Age 65 and Older
- Status
- COMPLETED
- Phase
- PHASE2
Study of SGN-40, Lenalidomide, and Dexamethasone in Patients With Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
Bortezomib and Dexamethasone With or Without Lenalidomide in Treating Patients With Multiple Myeloma Previously Treated With Dexamethasone
- Status
- TERMINATED
- Phase
- PHASE3
A Phase I Study of Lintuzumab Combined With Lenalidomide in Patients With Myelodysplastic Syndromes (MDS)
- Status
- COMPLETED
- Phase
- PHASE1
Valproic Acid-Based 2-Agent Oral Regimens for Patients With Advanced Solid Tumor
- Status
- COMPLETED
- Phase
- PHASE1
Lenalidomide, Sunitinib, and Cyclophosphamide in Treating Patients With Stage IV Eye Melanoma
- Status
- TERMINATED
- Phase
- PHASE2
A Study of Low Dose Lenalidomide and Dexamethasone in Relapsed/Refractory Myeloma in Patients at High Risk for Myelosuppression
- Status
- COMPLETED
- Phase
- PHASE2
A Multicenter, Single-Arm, Open-Label Expanded Access Program for Lenalidomide Plus Dexamethasone in Previously Treated Subjects With Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE3
Lenalidomide, Cyclophosphamide, and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Melphalan, Prednisone, and Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Lenalidomide in Treating Patients With Relapsed Mycosis Fungoides/Sezary Syndrome
- Status
- COMPLETED
- Phase
- PHASE2
Lenalidomide in Acute Leukemias and Chronic Lymphocytic Leukemia.
- Status
- COMPLETED
- Phase
- PHASE1
Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy
- Status
- COMPLETED
- Phase
- PHASE2
Lenalidomide, Dexamethasone, and Clarithromycin in Treating Patients Who Have Undergone Stem Cell Transplant for Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Lenalidomide and Vaccine Therapy in Treating Patients With Relapsed or Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2